Bg pattern

DOLOSTOP PEDIATRIC 100 mg/mL ORAL SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use DOLOSTOP PEDIATRIC 100 mg/mL ORAL SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

DolostopPediatric 100 mg/ml Oral Solution

Paracetamol

Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.

Follow the administration instructions for the medication contained in this package leaflet or as indicated by your doctor, pharmacist, or nurse.

  • Keep this package leaflet, as you may need to read it again.
  • If you need advice or more information, consult your pharmacist.
  • If you experience side effects, consult your doctor, pharmacist, or nurse, even if they are side effects not listed in this package leaflet. See section 4.
  • You should consult a doctor if your symptoms worsen or do not improve after 3 days. If the fever persists for more than 3 days or the pain for more than 3 days in children (2 days for throat pain).

Contents of the Package Leaflet:

  1. What Dolostop Pediatric is and what it is used for
  2. What you need to know before taking Dolostop Pediatric
  3. How to take Dolostop Pediatric
  4. Possible side effects
  5. Storage of Dolostop Pediatric
  6. Package Contents and Additional Information

1. What Dolostop Pediatric is and what it is used for

Paracetamol belongs to a group of medications called analgesics and antipyretics.

This medication is indicated for newborns, infants, and children for the treatment of febrile states and for the relief of mild or moderate pain.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before taking Dolostop Pediatric

Do not takeDolostopPediatric

  • If you are allergic (hypersensitive) to paracetamol or any of the other components of this medication (listed in section 6).
  • If you have a severe liver disease.

Warnings and Precautions

Consult your doctor or pharmacist before starting to take this medication.

  • Do not exceed the recommended dose in section 3. To do this, check that no other medications containing paracetamol are administered simultaneously.
  • Patient with mild or moderate liver disease should consult with their doctor before taking the medication.
  • Patient with kidney, heart, or lung disease, with anemia (decrease in hemoglobin level in the blood, due to or not due to a decrease in red blood cells), and in patients with chronic malnutrition or dehydration should consult with their doctor before taking the medication.
  • Consumption of alcoholic beverages can cause paracetamol to produce liver damage.
  • If the pain persists for more than 3 days (2 days for throat pain) or the fever for more than 3 days, or worsens or other symptoms appear, treatment should be discontinued and a doctor consulted. Avoid prolonged treatments.

During treatment with Dolostop, inform your doctor immediately if:

If you have severe diseases, such as severe renal failure or sepsis (when bacteria and their toxins circulate in the blood, causing damage to organs), or if you have malnutrition, chronic alcoholism, or are also taking flucloxacillin (an antibiotic). A severe disease called metabolic acidosis (an anomaly in blood and fluids) has been reported in patients in these situations when paracetamol is used at regular doses for a prolonged period or when paracetamol is taken with flucloxacillin. The symptoms of metabolic acidosis may include: severe breathing difficulties with deep and rapid breathing, drowsiness, feeling of discomfort (nausea) and vomiting.

Children

You should consult a doctor before administering this medication to children under 2 years of age.

Use ofDolostopPediatric with other medications

Inform your doctor or pharmacist that you are using or have recently used or may need to use any other medication.

Donotusewithothermedicationstotreatpainorfever(analgesics/antipyretics)unlessyourdoctortellsyoutodoso.

Paracetamol may increase the toxicity of chloramphenicol.

Barbiturates may potentiate the toxicity of paracetamol.

In case of treatment with oral anticoagulants, it can be administered occasionally as the analgesic of choice.

In particular, if you are using medications that contain any of the following active ingredients, it may be necessary to modify the dose or interrupt treatment of any of them:

  • Oral anticoagulants (acenocoumarol, warfarin).
  • Anticonvulsants (lamotrigine, phenytoin, phenobarbital, methylphenobarbital, primidone).
  • Antituberculars (isoniazid, rifampicin).
  • Colestyramine (used to decrease blood cholesterol levels).
  • Medications used to treat gout (anti-gout) (probenecid).
  • Some medications used to increase urine elimination (diuretics such as furosemide).
  • Metoclopramide and domperidone (used to prevent nausea and vomiting).
  • Propranolol used in the treatment of high blood pressure (hypertension) and heart rhythm disorders (cardiac arrhythmias).
  • Flucloxacillin (antibiotic), due to a serious risk of alteration of blood and fluids (called metabolic acidosis with high anion imbalance) that should be treated urgently (see section 2).

Interference with analytical tests:

If you are going to have any analytical tests (including blood tests, urine tests, skin tests that use allergens, etc.), inform your doctor that you are taking this medication, as it may alter the results of these tests.

Use ofDolostopPediatric with food, beverages, and alcohol

This medication can be taken with or without food and administered directly or diluted with water, milk, or fruit juice.

The use of paracetamol in patients who habitually consume alcohol (three or more alcoholic beverages per day) may damage the liver.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, or think you may be pregnant or plan to become pregnant, consult your doctor or pharmacist before using this medication.

Oral use of paracetamol does not produce undesirable effects in the pregnant woman, the fetus, or the newborn. Reproduction studies do not show malformations or toxic effects. If necessary, paracetamol can be used during pregnancy. You should use the lowest possible dose that reduces pain or fever and use it for the shortest possible time. Contact your doctor if the pain or fever does not decrease or if you need to take the medication more frequently.

Paracetamol passes into breast milk, although no communications of adverse effects in children have been reported. Therefore, it can be used in breastfeeding women if the recommended dose is not exceeded. Caution should be exercised in case of prolonged use.

Driving and using machines

It may decrease the ability to drive or operate machinery, as it contains propylene glycol, which can produce symptoms similar to those of alcohol.

DolostopPediatriccontains propylene glycol (E-1520)and glucose

This medication contains 2.72 mg of propylene glycol per ml.

If the baby is less than 4 weeks old, consult your doctor or pharmacist, especially if the baby has been administered other medications containing propylene glycol or alcohol.

This medication contains glucose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.

3. How to take Dolostop Pediatric

Follow the administration instructions for the medication contained in this package leaflet or as indicated by your doctor, pharmacist, or nurse. In case of doubts, ask your doctor or pharmacist.

Remember to take your medication.

Your doctor will indicate the duration of the treatment. Do not suspend the treatment before, as the expected results will not be obtained. Similarly, do not use this medication for longer than indicated by your doctor.

The dosage of the solution is performed in ml (100 mg/ml), using the oral syringe of 2 or 5 ml.

Use in children

The dose in children under 2 years of age should always be established by their doctor.

Children from 0 to 10 years:

The recommended daily dose of paracetamol is 60 mg/kg/day, i.e., 10 mg/kg every 4 hours (up to 6 doses/day) or 15 mg/kg every 6 hours (up to 4 doses in 24 hours). In children under 1 year, doses of 10 mg/kg are preferred.

For the administration of 10 mg/kgwith a minimum interval of 4 hours, the recommended schedule is as follows:

Child's weight

Age

(approximate)

Volume/dose

in ml

amount of paracetamol/dose

in mg

3 - 4 kg

from 0 to 3 months

0.4ml

40 mg

4 to 8 kg

from 4 to 11 months

0.4-0.8ml

40-80 mg

8 to 10 kg

from 12 to 23 months

0.8-1 ml

80-100 mg

10 to 15 kg

from 2 to 3 years

1-1.5ml

100-150 mg

15 to 20 kg

from 4 to 5 years

1.5-2.0ml

150-200 mg

20 to 25 kg

from 6 to 8 years

2.0-2.5ml

200-250 mg

25 to 32 kg

from 9 to 10 years

2.5-3.2ml

250-320 mg

For a direct calculation, the child's weight in kg can also be multiplied by 0.10. The result is the ml of solution to be administered.

These doses can be repeated every 4 hours.

Alternatively, doses of 15 mg/kgcan be administered with a minimum interval of 6 hours. In this case, for a direct calculation, the child's weight in kg can be multiplied by 0.15. The result is the ml of solution to be administered.

Administration of the preparation is subject to the appearance of painful or febrile symptoms. As these symptoms disappear, this medication should be discontinued.

If you estimate that the action of this medication is too strong or too weak, inform your doctor or pharmacist.

Method of use and route of administration

Oral route

Instructions for use:

1. Open the bottle by following the instructions on the cap (when opening for the first time, the seal will break).

2. Insert the oral syringe into the hole in the cap.

3. Invert the bottle and withdraw the necessary dose.

4. Administer directly or dilute with water, milk, or fruit juice.

5. The oral syringe should be washed with water after each dose.

Close the bottle well after each administration.

If you take moreDolostopPediatricthan you should

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.

If you have ingested an overdose, you should go quickly to a Medical Center, even if there are no symptoms, since often very serious symptoms do not manifest until 3 days after ingestion of the overdose, even in cases of severe poisoning. The symptoms of overdose may be: dizziness, vomiting, loss of appetite, yellowing of the skin and eyes (jaundice), and abdominal pain.

Paracetamol overdose is considered to be the ingestion of a single dose of more than 6 g in adults and more than 100 mg/kg of body weight in children. Treatment of the overdose is more effective if started within 4 hours of ingestion of the medication.

In the case of a patient being treated with barbiturates or suffering from chronic alcoholism, they may be more susceptible to a paracetamol overdose.

If you forget to takeDolostopPediatric

Do not take a double dose to make up for forgotten doses.

In case you have forgotten a dose, take another as soon as possible and continue with the usual schedule. However, if the time of the next dose is very close, skip the forgotten dose and take the next dose at the usual time.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medications, paracetamol can produce side effects, although not everyone experiences them.

This medication can produce the following side effects:

  • Rare (may affect up to 1 in 1,000 people): discomfort, increased liver transaminases, and low blood pressure.
  • Very rare (may affect up to 1 in 10,000 people): severe skin reactions, liver alterations (such as jaundice), low blood sugar, blood alterations (thrombocytopenia, agranulocytosis, leucopenia, neutropenia, hemolytic anemia), cloudy urine, and kidney alterations.
  • Frequency not known (cannot be estimated from available data): A serious disease that can make the blood more acidic (called metabolic acidosis) in patients with severe disease using paracetamol (see section 2).

Reporting of side effects

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a side effect not listed in this package leaflet. You can also report them directly through the Spanish Medication Surveillance System for human use: www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.

5. Storage of Dolostop Pediatric

Keep this medication out of sight and reach of children.

Store the bottle in the outer packaging to protect it from light.

Do not use this medication after the expiration date indicated on the packaging after "EXP". The expiration date is the last day of the month indicated.

Once opened, the contents of the bottle must be used within 6 months.

Medications should not be thrown away through the sewage system or in the trash. Deposit the packaging and medications you no longer need in the SIGRE collection point at your usual pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This way, you will help protect the environment.

6. Package Contents and Additional Information

Composition ofDolostopPediatric

  • The active ingredient is paracetamol. Each ml of solution contains 100 mg of paracetamol.
  • The other components (excipients) are: macrogol 600, glycerol (E-422), sucralose (E-955), flavor masker (contains propylene glycol (E-1520)), strawberry flavor (contains propylene glycol (E-1520)), carmine red (E-120) (contains glucose), and water.

Appearance of the product and package contents

Dolostop Pediatric 100 mg/ml Oral Solution is presented as a clear, red-colored solution with a characteristic strawberry flavor.

30 ml packaging:

Transparent plastic (PET) bottle with 30 ml of oral solution, with a plastic adapter (LDPE) to insert the dosing syringe and closed with a plastic cap (HDPE). A 2 ml plastic syringe is included.

60 ml packaging:

Transparent plastic (PET) bottle with 60 ml of oral solution. With a plastic adapter (LDPE) to insert the dosing syringe and closed with a plastic cap (HDPE). A 5 ml plastic syringe is included.

Marketing Authorization Holder and Manufacturer

Kern Pharma, S.L.

Venus, 72 - Pol. Ind. Colón II

08228 Terrassa - Barcelona

Spain

Date of the last revision of this package leaflet:February 2025

Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.

Online doctors for DOLOSTOP PEDIATRIC 100 mg/mL ORAL SOLUTION

Discuss questions about DOLOSTOP PEDIATRIC 100 mg/mL ORAL SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for DOLOSTOP PEDIATRIC 100 mg/mL ORAL SOLUTION?
DOLOSTOP PEDIATRIC 100 mg/mL ORAL SOLUTION does not require a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in DOLOSTOP PEDIATRIC 100 mg/mL ORAL SOLUTION?
The active ingredient in DOLOSTOP PEDIATRIC 100 mg/mL ORAL SOLUTION is paracetamol. This information helps identify medicines with the same composition but different brand names.
Who manufactures DOLOSTOP PEDIATRIC 100 mg/mL ORAL SOLUTION?
DOLOSTOP PEDIATRIC 100 mg/mL ORAL SOLUTION is manufactured by Kern Pharma S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of DOLOSTOP PEDIATRIC 100 mg/mL ORAL SOLUTION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether DOLOSTOP PEDIATRIC 100 mg/mL ORAL SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to DOLOSTOP PEDIATRIC 100 mg/mL ORAL SOLUTION?
Other medicines with the same active substance (paracetamol) include ABEZEN 1 G FILM-COATED TABLETS, ANTIDOL 1 G FILM-COATED TABLETS, ANTIDOL 1 G TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media